Tokyo, Oct. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059474) titled 'Retrospective study of cisplatin plus etoposide therapy in patients with lung cancer undergoing hemodialysis: the largest single-regimen cohort' on Oct. 21.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University Hospital
Condition:
Condition - Patients with Lung Cancer and end-stage renal failure undergoing HD
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To explore the safety and efficacy of cisplatin and etoposide therapy in patients with end-stage renal disease undergoing maintenance hemodialysis
Basic objectives2 - Safety
Eligibility:
A...